Shares closed at $315.13 on Wednesday, with trading volume reaching 2.9 million, above the 50-day average of 2.0 million.
This marks Stryker's second consecutive day of losses, leaving the stock 22.17% below its 52-week high of $404.87 set on July 23.
Despite the decline, Stryker outperformed competitors like Medtronic, Intuitive Surgical, and Edwards Lifesciences, which posted larger losses during the poor trading session.
After a $182M insider sale, is Stryker's stock drop a warning sign or a buying opportunity?
With new robotic rivals entering the market, is Stryker's dominance in surgery at risk?
As GLP-1 drugs curb obesity surgeries, how will medical device giants like Stryker pivot?
Did a cyberattack on Stryker just expose a critical vulnerability across the entire MedTech industry?
Will Stryker's Q1 earnings reveal the full cost of its crippling 'destructive wiper' cyberattack?
Can Stryker's new SmartHospital platform be trusted after a major cybersecurity breach?